Staphylococcus aureus biofilm development in medical devices

0

Reference:

Zapotoczna, M., McCarthy, H., Rudkin, J.K., O’Gara, J.P. and O’Neill, E. (2015) An essential role for coagulase in Staphylococcus aureus biofilm development reveals new therapeutic possibilities for device-related infections. The Journal of Infectious Diseases. June 4th. [epub ahead of print].

Abstract:

High level resistance to antimicrobial drugs is a major factor in the pathogenesis of chronic Staphylococcus aureus biofilm-associated, medical device-related infections. Antimicrobial susceptibility analysis revealed that biofilms (≤ 24h) grown on biomaterials conditioned with human plasma under venous shear in iron-free cell culture media were significantly more sensitive to anti-staphylococcal antibiotics. Biofilms formed under these physiologically-relevant conditions were SaeRS-regulated and dependent on coagulase-catalysed conversion of fibrinogen into fibrin. In contrast, SarA-regulated biofilms formed on uncoated polystyrene in nutrient-rich bacteriological media were mediated by the previously characterised biofilm factors poly-N-acetyl glucosamine, fibronectin-binding proteins or autolytic activity and were antibiotic resistant. Coagulase-mediated biofilms exhibited increased antimicrobial resistance over time (>48h) but were always susceptible to dispersal by the fibrinolysins; plasmin or nattokinase. Biofilms recovered from infected central venous catheters in a rat model of device-related infection were dispersed by nattokinase supporting the important role of the biofilm phenotype and identifying a potentially new therapeutic approach with antimicrobials and fibrinolytic drugs, particularly during the early stages of device-related infection.

Thank you to our partners for supporting IVTEAM

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.